Barr, Kos Pharma In Talks To Settle Niaspan Patent Litigation
Barr Pharmaceuticals Inc. and Kos Pharmaceuticals Inc. are in talks to settle their outstanding patent litigation regarding Kos' cholesterol reducing drug Niaspan, the two companies said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article